Skip to the page

Data / Drug companies / l-Thyroxine

l-Thyroxine drugs: 7 drugs from 59 companies in the FDA NDC directory

l-Thyroxine is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 656 products in this class from 59 companies, covering 7 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 31, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 59Companies
  • 656Products
  • 7Drugs by generic name

Drugs in the l-Thyroxine class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Levothyroxine sodium56544
Levothyroxine, liothyronine249
Levothyroxine sodium anhydrous196
Levothyroxine and liothyronine152
Thyroid tablets151
Levothyroxine liothyronine11
Levothyroxinum11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions77tabletGeneric drugs (ANDA)April 8, 2025
Bryant Ranch Prepack47tabletGeneric drugs (ANDA)December 21, 2022
Northwind Health Company, LLC36tabletGeneric drugs (ANDA)March 30, 2023
Ibsa Pharma Inc.30capsule; solutionNew drug applications (NDA)March 1, 2023
Preferred Pharmaceuticals Inc.28tabletGeneric drugs (ANDA)April 20, 2026
NuCare Pharmaceuticals,Inc.20tabletGeneric drugs (ANDA)April 8, 2025
Proficient Rx LP17tabletNew drug applications (NDA)December 10, 2020
Calvin Scott & Co., Inc.15tabletOther unapproved drugsAugust 1, 2025
Direct_Rx15tabletNew drug applications (NDA)January 9, 2025
Alvogen Inc.14tabletNew drug applications (NDA)May 7, 2019
Proficient Rx LP14tabletGeneric drugs (ANDA)September 21, 2022
Cardinal Health 107, LLC13tabletGeneric drugs (ANDA)May 2, 2019
Coupler LLC13tabletGeneric drugs (ANDA)July 6, 2026
Remedyrepack Inc.13tabletGeneric drugs (ANDA)August 13, 2025
AbbVie Inc.12tabletNew drug applications (NDA)July 24, 2002
Accord Healthcare Inc.12tabletGeneric drugs (ANDA)December 10, 2020
Amneal Pharmaceuticals LLC12tabletNew drug applications (NDA)July 3, 2014
Amneal Pharmaceuticals NY LLC12tabletAuthorized generics (NDA)October 1, 2007
Asclemed USA Inc.12tabletGeneric drugs (ANDA)December 10, 2020
Camber Pharmaceuticals, Inc.12tabletGeneric drugs (ANDA)January 18, 2023
Lannett Company, Inc.12tabletAuthorized generics (NDA)August 3, 2020
Lupin Pharmaceuticals, Inc.12tabletGeneric drugs (ANDA)May 2, 2019
Macleods Pharmaceuticals Limited12tabletGeneric drugs (ANDA)December 21, 2022
XLCare Pharmaceuticals, Inc.12tabletGeneric drugs (ANDA)January 18, 2023
Yaral Pharma Inc.12capsuleAuthorized generics (NDA)March 1, 2023
American Health Packaging11tabletGeneric drugs (ANDA)January 5, 2021
Fresenius Kabi USA, LLC11injection, powder, lyophilized, for solution; injection, solutionNew drug applications (NDA)May 29, 2018
NorthStar RxLLC11tabletGeneric drugs (ANDA)April 8, 2025
Pfizer Laboratories Div Pfizer Inc11tabletNew drug applications (NDA)May 25, 2001
Bryant Ranch Prepack10tabletAuthorized generics (NDA)August 3, 2020
NCS HealthCare of Ky, LLC DBA Vangard Labs10tabletNew drug applications (NDA)October 1, 2007
Bryant Ranch Prepack9tabletAuthorized generics (NDA)August 3, 2020
Major Pharmaceuticals9tabletGeneric drugs (ANDA)May 2, 2019
Genus Lifesciences8tabletOther unapproved drugsMarch 1, 2025
Energique, Inc.7liquidUnapproved homeopathic productsFebruary 18, 2026
Trifluent Pharma, LLC7tabletOther unapproved drugsOctober 12, 2025
Acella Pharmaceuticals, LLC6tabletOther unapproved drugsOctober 31, 2026
Mylan Institutional Inc.6tabletGeneric drugs (ANDA)February 26, 2007
Apex Energetics Inc.5solution/ dropsUnapproved homeopathic productsMarch 22, 2022
Asclemed USA, Inc.5tabletOther unapproved drugsJune 12, 2017
Aurobindo Pharma Limited5tabletGeneric drugs (ANDA)July 16, 2024
Teva Pharmaceuticals, Inc.5tabletGeneric drugs (ANDA)September 21, 2022
Mylan Institutional Inc.4tabletGeneric drugs (ANDA)January 14, 2019
Guna Spa3solution/ dropsUnapproved homeopathic productsSeptember 24, 2020
Maia Pharmaceuticals, Inc.3injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 27, 2018
Onesource Specialty Pharma Limited3injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 27, 2026
Par Health USA, LLC3injection, powder, lyophilized, for solutionNew drug applications (NDA)June 24, 2011
Redpharm Drug3tabletGeneric drugs (ANDA)December 10, 2020
Sagent Pharmaceuticals3injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 1, 2024
Zydus Pharmaceuticals USA Inc.3injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 1, 2024
PD-Rx Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)December 10, 2020
Piramal Critical Care Inc2injectionGeneric drugs (ANDA)October 1, 2022
BioActive Nutritional, Inc.1liquidUnapproved homeopathic productsJuly 29, 2021
Fosun Pharma USA Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 16, 2025
Hikma Pharmaceuticals USA Inc.1injection, solutionNew drug applications (NDA)November 15, 2022
Northwind Health Company, LLC1tabletGeneric drugs (ANDA)July 5, 2023
Oliva Therapeutics, LLC1solutionNew drug applications (NDA)July 1, 2025
The Wellness Center for Research and Education, Inc.1liquidUnapproved homeopathic productsJune 3, 2020
Zydus Lifesciences Limited1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 1, 2024

Dosage forms

Dosage formProductsShare
Tablet56586.1%
Capsule274.1%
Injection, powder, lyophilized, for solution233.5%
Solution162.4%
Liquid91.4%
Solution/ drops81.2%
Injection, solution60.9%
Injection20.3%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.